CAS NO: | 138148-68-2 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
Cas No. | 138148-68-2 |
别名 | N2'-去乙酰基-N2'-[3-(甲基二硫基)-1-氧代丙基]美登素 |
化学名 | N2'-deacetyl-N2'-[3-(methyldithio)-1-oxopropyl]-maytansine |
Canonical SMILES | C[C@@]1([C@@H](O1)[C@H](C)[C@]([H])(C[C@](N2)(O)[C@]([H])(OC)/C=C/C=C(CC3=CC(OC)=C(Cl)C4=C3)\C)OC2=O)[C@@]([H])(OC([C@@H](N(C)C(CCSSC)=O)C)=O)CC(N4C)=O |
分子式 | C36H50ClN3O10S2 |
分子量 | 784.4 |
溶解度 | DMF: 16 mg/ml,DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml,DMSO: 12 mg/ml |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
半岛bd体育手机客户端 描述 | DM1-SMe is an analog of mertansine with a thiomethane cap attached to the sulfhydryl group. It has in vitro activity against the pediatric preclinical testing program (PPTP) panel of cancer cell lines with IC50 values of 0.002 to >3 nM. References: [1]. Wood, A.C., Maris, J.M., Gorlick, R., et al. Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program Pediatr. Blood Cancer 60(11), 1860-1867 (2013). |